Evidence map›Paper›PMID 21239639›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2011

Active tension adaptation at a shortened arterial muscle length: inhibition by cytochalasin-D.

Melissa L Bednarek, John E Speich, Amy S Miner, Paul H Ratz

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

  1. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Melissa L BednarekDepartments of Physiology, School of Engineering, Virginia Commonwealth University, Richmond, 23298-0614, USA. mbednarek@chatham.edu
John E Speich
Amy S Miner
Paul H Ratz
Pediatrics and Genetics · USVirginia Commonwealth University · US

Funding

Regulation of vascular smooth muscle calcium sensitivityR01HL061320 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI RATZ, PAUL H · 2001 to 2010
$2.3M
NHLBI NIH HHS R01-HL-61320
6 · The paper itself

Abstract

Unlike the static length-tension curve of striated muscle, airway and urinary bladder smooth muscles display a dynamic length-tension curve. Much less is known about the plasticity of the length-tension curve of vascular smooth muscle. The present study demonstrates that there were significant increases of ∼15% in the phasic phase and ∼10% in the tonic phase of a third KCl-induced contraction of a rabbit femoral artery ring relative to the first contraction after a 20% decrease in length from an optimal muscle length (L(0)) to 0.8-fold L(0). Typically, three repeated contractions were necessary for full length adaptation to occur. The tonic phase of a third KCl-induced contraction was increased by ∼50% after the release of tissues from 1.25-fold to 0.75-fold L(o). The mechanism for this phenomenon did not appear to lie in thick filament regulation because there was no increase in myosin light chain (MLC) phosphorylation to support the increase in tension nor was length adaptation abolished when Ca(2+) entry was limited by nifedipine and when Rho kinase (ROCK) was blocked by H-1152. However, length adaptation of both the phasic and tonic phases was abolished when actin polymerization was inhibited through blockade of the plus end of actin by cytochalasin-D. Interestingly, inhibition of actin polymerization when G-actin monomers were sequestered by latrunculin-B increased the phasic phase and had no effect on the tonic phase of contraction during length adaptation. These data suggest that for a given level of cytosolic free Ca(2+), active tension in the femoral artery can be sensitized not only by regulation of MLC phosphatase via ROCK and protein kinase C, as has been reported by others, but also by a nonmyosin regulatory mechanism involving actin polymerization. Dysregulation of this form of active tension modulation may provide insight into alterations of large artery stiffness in hypertension.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineActinsAnimalsBridged Bicyclo Compounds, HeterocyclicCalcium Channel BlockersCalcium ChannelsCytochalasin DFemoral ArteryMuscle ContractionMuscle, Smooth, VascularMuscle TonusMyosin Light ChainsNifedipinePhosphorylationPotassium ChlorideRabbits1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazineActinsBridged Bicyclo Compounds, HeterocyclicCalcium Channel BlockersCalcium ChannelsCytochalasin Dlatrunculin BMyosin Light ChainsNifedipinePotassium Chloriderho-Associated KinasesThiazolidines

Identifiers

PMID21239639
PMCPMC3075030
OpenAlexW2155292930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.